Drug Development in Dementia

Dementia has only little treatment to regulate and cure the patient and much of treatment gone failure. Drug development for the dementia is that the tedious one. the primary drug was approved within the year 2003 and there's no other approval for the dementia drug development. So, the drug development for the dementia goes to be complex.

New research on dementia goes on using the amyloid, tau, and neurodegeneration condition within the national institute of aging. This framework produces the more stages of dementia. The drug discovery mainly specialises in the repurposing of the drugs, which suggests the drug is already used for several other conditions and this medicine is again used for the dementia with some modification therein chemicals. The drugs developed for dementia are


  • Track 1-1 Gantenerumab
  • Track 2-2 Solanezumab

Related Conference of Neuroscience